Medicamen Biotec

{
  "main_header": {
    "sid": 770569,
    "name": "Medicamen Biotec",
    "stock_name": "Medicamen Biotec",
    "full_name": "Medicamen Biotech Ltd",
    "name_url": "stocks-analysis/medicamen-biotec",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "276.15",
    "chg": 0.95,
    "chgp": "0.35%",
    "dir": 1,
    "prev_price": "275.20",
    "mcapval": "374.54 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531146,
    "symbol": "MEDICAMEQ",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE646B01010",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "32.09 k",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medicamen-biotec-770569-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Medicamen Biotech Ltd Stock Hits 52-Week Low at Rs.270",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-hits-52-week-low-at-rs270-3888761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3888761.png",
        "date": "2026-03-13 10:01:48",
        "description": "Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.270 on 13 Mar 2026, marking a significant downturn amid broader market weakness and persistent underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-market-challenges-3888008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_valuationdot_3888008.png",
        "date": "2026-03-13 08:00:46",
        "description": "Medicamen Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside other key financial metrics, reveal a complex picture of valuation attractiveness contrasted with operational and market headwinds."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs.275.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-of-rs27595-3887222",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3887222.png",
        "date": "2026-03-12 15:06:52",
        "description": "Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.275.95 on 12 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and key benchmarks, reflecting ongoing pressures in the Pharmaceuticals & Biotechnology space."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3882502",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_mojoScore_3882502.png",
        "date": "2026-03-10 10:10:18",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 10 March 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects."
      },
      {
        "title": "Medicamen Biotech Ltd Stock Falls to 52-Week Low of Rs.277.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-falls-to-52-week-low-of-rs27705-3864809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3864809.png",
        "date": "2026-03-02 12:25:48",
        "description": "Medicamen Biotech Ltd’s share price declined sharply to a new 52-week low of Rs.277.05 today, marking a significant downturn amid broader market fluctuations. The stock opened with an 8% gap down and has now fallen for two consecutive sessions, underperforming its sector and the broader market indices."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3857789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicamenBiotec_mojoScore_3857789.png",
        "date": "2026-02-26 10:10:24",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs.292.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-of-rs29205-3855815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicamenBiotec_priceRelatedfactors_3855815.png",
        "date": "2026-02-25 14:38:10",
        "description": "Medicamen Biotech Ltd’s shares declined sharply to a new 52-week low of Rs.292.05 on 25 Feb 2026, marking a significant drop amid broader market gains. The stock underperformed its sector and key benchmarks, reflecting ongoing concerns about its financial performance and valuation metrics."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3840982",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicamenBiotec_mojoScore_3840982.png",
        "date": "2026-02-15 10:10:07",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Are Medicamen Biotech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-medicamen-biotech-ltd-latest-results-good-or-bad-3838159",
        "imagepath": "",
        "date": "2026-02-13 19:52:50",
        "description": "Medicamen Biotech Ltd's latest financial results for Q2 FY26 indicate a company navigating a complex operational landscape. The company reported net sales of ₹47.17 crores, reflecting a year-on-year growth of 5.43%, which is an improvement compared to the previous year. This marks a recovery from a significant decline in the prior quarter, showcasing a return to revenue growth after a challenging period.\n\nConsolidated net profit for the quarter reached ₹2.67 crores, representing a substantial year-on-year increase of 82.88%. This profit growth is notable as it continues a trend of sequential improvement over the past three quarters, suggesting that operational efficiencies may be beginning to take hold. However, it is important to note that this profit level remains below the ₹3.47 crores achieved in Q4 FY25, indicating ongoing volatility in earnings.\n\nDespite the positive trends in sales and profit, the co..."
      }
    ],
    "total": 6220,
    "sid": "770569",
    "stock_news_url": "https://www.marketsmojo.com/news/medicamen-biotech-770569"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medicamen Biotech Ltd Stock Hits 52-Week Low at Rs.270

2026-03-13 10:01:48

Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.270 on 13 Mar 2026, marking a significant downturn amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.

Read full news article

Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges

2026-03-13 08:00:46

Medicamen Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside other key financial metrics, reveal a complex picture of valuation attractiveness contrasted with operational and market headwinds.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs.275.95

2026-03-12 15:06:52

Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.275.95 on 12 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and key benchmarks, reflecting ongoing pressures in the Pharmaceuticals & Biotechnology space.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-03-10 10:10:18

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 10 March 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects.

Read full news article

Medicamen Biotech Ltd Stock Falls to 52-Week Low of Rs.277.05

2026-03-02 12:25:48

Medicamen Biotech Ltd’s share price declined sharply to a new 52-week low of Rs.277.05 today, marking a significant downturn amid broader market fluctuations. The stock opened with an 8% gap down and has now fallen for two consecutive sessions, underperforming its sector and the broader market indices.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-02-26 10:10:24

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs.292.05

2026-02-25 14:38:10

Medicamen Biotech Ltd’s shares declined sharply to a new 52-week low of Rs.292.05 on 25 Feb 2026, marking a significant drop amid broader market gains. The stock underperformed its sector and key benchmarks, reflecting ongoing concerns about its financial performance and valuation metrics.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-02-15 10:10:07

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Medicamen Biotech Ltd latest results good or bad?

2026-02-13 19:52:50

Medicamen Biotech Ltd's latest financial results for Q2 FY26 indicate a company navigating a complex operational landscape. The company reported net sales of ₹47.17 crores, reflecting a year-on-year growth of 5.43%, which is an improvement compared to the previous year. This marks a recovery from a significant decline in the prior quarter, showcasing a return to revenue growth after a challenging period. Consolidated net profit for the quarter reached ₹2.67 crores, representing a substantial year-on-year increase of 82.88%. This profit growth is notable as it continues a trend of sequential improvement over the past three quarters, suggesting that operational efficiencies may be beginning to take hold. However, it is important to note that this profit level remains below the ₹3.47 crores achieved in Q4 FY25, indicating ongoing volatility in earnings. Despite the positive trends in sales and profit, the co...

Read full news article

View All News